Clinical Trial Update: Butrans for Treatment of Restless Legs Syndrome [Phase 4]

View source ↗

Summary

Phase 4 clinical trial of Butrans for restless legs syndrome has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Restless Legs Syndrome

Drugs mentioned

• BUTRANS (Buprenorphine)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Restless Legs Syndrome | Phase 4 | Status: WITHDRAWN